AIO-Studien-gGmbH
aio-portal.deTotal trials
59
Active
6
Phase 3
6
Total enrollment
23,475
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 4 of 4 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Atezolizumab | — | — | — | — | — | 2 | |
| Maximum tolerated dose, MTD: D,L-methadone hydrochloride | — | — | — | — | — | 1 | |
| IMM-101 | — | — | — | — | — | 1 | |
| Osimertinib | — | — | — | — | — | 1 |
Next readouts
- 2025-12
- 2026-03
- 2027-04
Top conditions
- Metastatic Colorectal Cancer3
- Colorectal Neoplasms3
- Esophageal Cancer2
- GastroEsophageal Cancer2
- Biliary Tract Cancer2
- Metastatic Pancreatic Cancer2
- Colorectal Cancer2
- Ductal Adenocarcinoma of the Pancreas2
Frequently asked questions about AIO-Studien-gGmbH
- How many clinical trials does AIO-Studien-gGmbH have on ClinicalTrials.gov?
- AIO-Studien-gGmbH is listed as the lead sponsor on 59 clinical trials in ClinicalTrials.gov, 6 of which are currently active (recruiting, enrolling, or ongoing).
- How many of AIO-Studien-gGmbH's trials are in Phase 3?
- 6 of AIO-Studien-gGmbH's trials are in Phase 3, spread across 4 active drug programs.
- What therapeutic areas does AIO-Studien-gGmbH focus on?
- AIO-Studien-gGmbH's most-studied conditions on ClinicalTrials.gov are Metastatic Colorectal Cancer, Colorectal Neoplasms, Esophageal Cancer, GastroEsophageal Cancer, Biliary Tract Cancer.
- When are AIO-Studien-gGmbH's next clinical trial readouts?
- AIO-Studien-gGmbH has 3 upcoming primary-completion readouts tracked here; the soonest is “D,L-MEthadone and mFOLFOX6 in Treatment of Advanced Colorectal Cancer”, expected around 2025-12.